Genitourinary Cancer
  • Featured content
    In this downloadable slideset, M. Dror Michaelson, MD, PhD, explores the data and clinical guidelines on the optimal use of immune checkpoint inhibitors for treating renal cell carcinoma.
    Date Posted: 6/7/2017
  • Featured content
    In this downloadable slideset, Elizabeth R. Plimack, MD, MS, discusses the data and clinical guidelines on the optimal use of immune checkpoint inhibitors for treating advanced urothelial cell carcinoma.
    Date Posted: 6/7/2017
  • Featured content
    Download this pocket guide for information on dosing, administration, and clinical management for the current FDA-approved checkpoint inhibitor, nivolumab, in advanced RCC. This pdf includes a checklist for assessing your patients for common immune-related adverse events in the clinic.
    Date Posted: 5/24/2017
  • Featured content
    David R. Gandara, MD; Daniel M. Geynisman, MD; Sara Hurvitz, MD, FACP; Elias Jabbour, MD; Shaji Kumar, MD; Brian Rini, MD, FACP; Tiffany A. Traina, MD; and Heather A. Wakelee, MD, each provide an analysis of key presentations on cancer immunotherapy from the 2016 clinical oncology meeting in Chicago.
  • Featured content
    David R. Gandara, MD; Daniel M. Geynisman, MD; Sara Hurvitz, MD, FACP; Elias Jabbour, MD; Shaji Kumar, MD; Brian Rini, MD, FACP; Tiffany A. Traina, MD; and Heather A. Wakelee, MD, provide an analysis of key presentations on cancer immunotherapy from the 2016 Clinical Oncology meeting in Chicago.
    Date Posted: 9/19/2016
  • 1
  • 2
  • 3
  • 4
  • 5

Latest Content

10 of 92 Shown
10 of 92 Shown
Show 10 More
Loading...